Overview
Reoptis is an ophthalmology clinic offering laser vision correction using SmartSight and FemtoLASIK, as well as lens-based correction, including refractive lens exchange. Its services also include cataract surgery, cross-linking, laser and eyelid-area procedures, intravitreal injections, and pediatric ophthalmology.
Financials
Revenue history (in k)
Filing timeliness
1 of 6 financial statements was filed late (for 2021, 38 days late).
- 202517/04/2026
- 202421/05/2025
- 202316/05/2024
- 202201/06/2023
- 202122/08/2022
- 202003/08/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
National Health Fund (NFZ) contracts
Reoptis has been an NFZ healthcare provider since 2021. In 2026 it is performing 1 contract worth USD 1.52m. All its contracts were worth USD 4.29m in total.
NFZ contract value by year (in k USD)
| Type of care | NFZ branch | Contracts | Value in 2026 |
|---|---|---|---|
| Inpatient treatment | wielkopolskie | 1 | USD 1.52m |
NFZ waiting lists
This company's facilities run 1 NFZ waiting list. Waiting time forecast by NFZ, as of 02.10.2026.
| Service | Waiting time | Urgent | Waiting | |
|---|---|---|---|---|
| Treatment of patients with retinal diseases (AMD, DME) | 1 day | no wait | 0 |
Trademarks
Reoptis currently holds no active trademarks with the Polish Patent Office. 1 application is pending. The first mark was filed in 2025.
| Mark | Protected until | |
|---|---|---|
| REOPTIS | – |
Authorized Representatives
Manner of representation
If a one-person management board is appointed, the President of the Management Board is authorised to make declarations on behalf of the company, and if a multi-member management board is appointed, each member of the management board acting independently is authorised.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Andrzej Dmitriewage 49 | 285 | $76,985.41 | 57% |
Wojciech Jerzy Golusińskiage 70 | 95 | $25,661.80 | 19% |
Piotr Stanisław Mrugalskiage 63 | 95 | $25,661.80 | 19% |
Others | 25 | $6,753.11 | 5% |
Beneficial owners
| Person | Rights |
|---|---|
Debt
No entries in the National Debtors Register (KRZ).
Real estate
| Type | Amount |
|---|---|
Buildings and premises | PLN 1.3MPLN 1,260,109 |
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Mar 5, 2021 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $37,948$37,948 | Poznański Fundusz Poręczeń Kredytowych sp. z o.o. |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Kardiotelsp. z o.o. | $6,094,977.61 | kardiotel.pl | ||
| Mega-Lenssp. z o.o. | $3,290,632.61 | megalens.pl | ||
| Mandala Beauty Clinicsp. z o.o. | $2,785,719.15 | mandalaclinic.com | ||
| Retina Okulistyka Fryczkowskisp. k. | $2,243,363.51 | retina.pl | ||
| Ortoidea Jaroszyksp. k. | $2,045,465.25 | ortoidea.pl | ||
| Ortodontica Dental Clinicsp. z o.o. | $1,949,670.36 | ortodonta-poznan.com | ||
| Swisslasersp. z o.o. | $1,645,175.84 | swisslaser.pl | ||
| Idealny Wzroksp. z o.o. | $1,581,582.91 | idealnywzrok.pl | ||
| Visus-Kalsp. z o.o. | $1,350,239.21 | visus-kal.pl | ||
| Swisslaser Krakówsp. z o.o. | $1,186,162.33 | swisslaser.pl |
Change history
| Date | Event | |
|---|---|---|
| 2021-04-15 | Name change (Nanoptica → Reoptis) | |
| 2016-03-22 | Entered in the register |
FAQ
Last updated: 2026-04-17